Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 472 record(s)

Req # A-2018-001052

All Electronic documents that pertain to Essure Permanent Birth Control System.

Organization: Health Canada

2286 page(s)
November 2023

Req # A-2020-000373

All briefing notes and related materials given to Minister Hajdu related to the coronavirus, Covid 19 in May.

Organization: Health Canada

177 page(s)
November 2023

Req # A-2020-000554

Concerning your access to information statistical report for fiscal year 2018/19 https://www.canada.ca/content/dam/tbs-sct/documents/access-information-privacy/2018-19-ati-eng.csv, please provide: the file number; in relation to the item, the date of any request for clarification; in relation to the item, the date of any extension of time.

Organization: Health Canada

2656 page(s)
November 2023

Req # A-2020-000672

All records concerning the refusal of Chinese officials to ship the CanSino Biologics Ad5-nCoV vaccine to Canada and the abandonment of the testing program. Time period: May 1, 2020 to September 1, 2020.

Organization: Health Canada

60 page(s)
November 2023

Req # A-2021-000082

Requesting 100 written submissions received by Health Canada in response to the online engagement on a National Strategy for High Cost Drugs for Rare diseases which ran from January 27, 2021 to March 26, 2021.

Organization: Health Canada

8 page(s)
November 2023

Req # A-2022-000164

In the Memorandum of Understanding (MOU) signed by the federal government and provinces and territories (P/T's) that governs the blood system - section 5.4, - Health Canada is obliged to provide annual reports to Canadian Biosafety Standard (CBS) Members” (P/T’s) to “report onHealth Canada regulatory policies and decisions in relation to blood” and meet twice annually with Members to discuss issues of mutual concern re the blood system. Provide copies of these annual reports between 2015-2022.

Organization: Health Canada

0 page(s)
November 2023

Req # A-2022-000823

All communications with representatives of Twitter, regarding the potential or actual removal of content described as “misinformation”, “disinformation”, “harmful”, "false", "conspiracy", "anti-vax", "anti-vaccination", "election denying", a “conspiracy”, a “conspiracy theory", "far right", "far right wing", “extremist”, "far right wing extremist”, since January 1, 2018.

Organization: Health Canada

4 page(s)
November 2023

Req # A-2022-001233

All records between September 20, 2020 to December 31, 2020 which make any reference to the changes that were made to the noted webpage. https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting/vaccine/consumer.html

Organization: Health Canada

458 page(s)
November 2023

Req # A-2022-001514

Health Canada has recently signed an agreement with British Columbia (BC) for health data sharing. Provide copy of agreement signed between Feb 1, 2023 and March 2, 2023 between Health Canada and the province of BC. Provide the agreement definition of what ‘‘depersonalized‘‘ health data means. Provide all data points or fields of health information that will be shared between the province of BC and Health Canada under this agreement.

Organization: Health Canada

18 page(s)
November 2023

Req # A-2023-000016

The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-03-24 for the medicinal ingredient Doxorubicin. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for Doxorubicin which appears in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-03-24. The strength (s) and dosage form of any and all generic drugs in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2023-03-24 for the medicinal ingredient Doxorubicin.

Organization: Health Canada

4 page(s)
November 2023
Date modified: